Radiomics in Liquid Biopsies
نویسندگان
چکیده
منابع مشابه
Emerging concepts in liquid biopsies
Characterizing and monitoring tumor genomes with blood samples could achieve significant improvements in precision medicine. As tumors shed parts of themselves into the circulation, analyses of circulating tumor cells, circulating tumor DNA, and tumor-derived exosomes, often referred to as "liquid biopsies", may enable tumor genome characterization by minimally invasive means. Indeed, multiple ...
متن کاملThe potential of liquid biopsies.
PURPOSE OF REVIEW This article discusses the current status and applications of liquid biopsy in nonsmall cell lung cancer (NSCLC). RECENT FINDINGS The discovery of genetic alterations which are responsible for the development and progression of NSCLC led to the identification of a new generation of molecular biomarkers. However, in NSCLC, it is often difficult in clinical practice to obtain ...
متن کاملLiquid biopsies for bladder cancer
The development of accurate urinary biomarkers for the non-invasive detection of urothelial bladder cancer (UBC) could transform patient pathways by reducing reliance on cystoscopy, and the identification of highly prognostic (or even predictive) biomarkers could better guide patient management. A number of approaches are being utilised to address these challenges in both urinary- and plasma-bo...
متن کاملLiquid Biopsies: Handle With Care
Possibly the first mention of the term ‘liquid biopsy’ (as it is understood today) in the scientific literature appears in a report about the 7th International Symposium on Minimal Residual Cancer (ISMRC) held in Athens, Greece in 2009.1 The symposium had focused on, among other things, Circulating Tumor Cells (CTCs) and their relationship to Cancer Stem Cells (CSCs). In that symposium, it was ...
متن کاملLiquid biopsies transform lung cancer therapy
This article was written by Dr Lukas C Heukamp, medical director of NEO New Oncology AG in Cologne, Germany, [email protected]. Understanding how genetic alterations drive tumour growth and progression in virtually all cancer indications is revolutionising cancer treatment. Modern medicine takes advantage of the weak points of a tumour by developing so-called targeted drugs. In lung cancer, m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2016
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(16)30240-7